Francisco Cajade-Pascual

5PUBLICATIONS
23CO-AUTHORS
Medical virologyMedical infection agents (incl. prions)Artificial life and complex adaptive systemsPharmacogenomicsHumoural immunology and immunochemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 18, 2026
Simultaneous quantification of linezolid and its metabolites (PNU-142300 and PNU-142586) in oral fluid and capillary blood by UPLC-MS/MS: method validation and clinical application using non-invasive sampling techniques.

|Jun 10, 2026
Prolonged linezolid therapy induces progressive mitochondrial dysfunction in human peripheral blood mononuclear cells.

|Jan 08, 2025
Artificial Intelligence and Machine Learning Applications to Pharmacokinetic Modeling and Dose Prediction of Antibiotics: A Scoping Review.

Iria Varela-Rey, Enrique Bandín-Vilar, Francisco José Toja-Camba

|Oct 30, 2024
Safety and efficacy of personalised versus standard dosing of linezolid in patients with sepsis (SePkLin): a pragmatic, multicentre, randomised, controlled and superiority clinical trial protocol.

Enrique Bandín-Vilar, Ana Estany-Gestal, Teresa Cabaleiro

|Nov 25, 2023
Enhancing Therapeutic Drug Monitoring in Inflammatory Bowel Disease: A Comparative Analysis of Rapid Point-of-Care Infliximab, Adalimumab and Anti-Drug Antibodies' Determination against ELISA.

Francisco José Toja-Camba, Laura García-Quintanilla, Lorena Rodríguez-Martinez

Pageof 1

Frequent Collaborators

4 joint publications

Cristina Mondelo-García

4 joint publications

Anxo Fernández-Ferreiro

2 joint publications

Francisco José Toja-Camba

2 joint publications

Irene Zarra-Ferro